These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30212418)

  • 1. Ethosuximide-induced Thrombocytopenia: A Case Report.
    Shatara M; Regling K; Sabo C; Figueroa M; Taub JW; Rajpurkar M
    J Pediatr Hematol Oncol; 2019 Jul; 41(5):420-421. PubMed ID: 30212418
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethosuximide induced lymphadenopathy--a case report.
    Ojinnaka NC; Iloeje SO
    Cent Afr J Med; 2001 Jan; 47(1):18-9. PubMed ID: 11961853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug induced pseudolymphoma secondary to ethosuximide.
    Masruha MR; Marques CM; Vilanova LC; de Seixas Alves MT; Peres MF; Rodrigues MG
    J Neurol Neurosurg Psychiatry; 2005 Nov; 76(11):1610. PubMed ID: 16227569
    [No Abstract]   [Full Text] [Related]  

  • 4. Ethosuximide-induced lupus-scleroderma syndrome with disease-specific autoantibodies.
    Toyama T; Asano Y; Taniguchi T; Takahashi T; Ichimura Y; Tamaki Z; Kagami S; Mitsui H; Sato S
    Eur J Dermatol; 2017 Apr; 27(2):196-197. PubMed ID: 28026802
    [No Abstract]   [Full Text] [Related]  

  • 5. Ethosuximide-associated lupus with cerebral and renal manifestations.
    Casteels K; Van Geet C; Wouters K
    Eur J Pediatr; 1998 Sep; 157(9):780. PubMed ID: 9776542
    [No Abstract]   [Full Text] [Related]  

  • 6. Ethosuximide-induced de novo systemic lupus erythematosus with anti-double-strand DNA antibodies: a case report with definite evidence.
    Crespel A; Velizarova R; Agullo M; Gélisse P
    Epilepsia; 2009 Aug; 50(8):2003. PubMed ID: 19682032
    [No Abstract]   [Full Text] [Related]  

  • 7. Acneiform eruption induced by ethosuximide.
    Ricci F; Paradisi A; Masini F; Contaldo I; Battaglia DI; Capizzi R; Guerriero C
    Eur J Dermatol; 2014; 24(1):98-9. PubMed ID: 24334200
    [No Abstract]   [Full Text] [Related]  

  • 8. Ethosuximide-induced conversion of typical childhood absence to Rolandic spikes.
    Anyanwu C; Ghavami F; Schuelein M; Motamedi GK
    J Child Neurol; 2013 Jan; 28(1):111-4. PubMed ID: 22467741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethosuximide-induced lupus-like syndrome with renal involvement.
    Takeda S; Koizumi F; Takazakura E
    Intern Med; 1996 Jul; 35(7):587-91. PubMed ID: 8842769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethosuximide induced agranulocytosis.
    Imai T; Okada H; Nanba M; Kawada K; Kusaka T; Itoh S
    Brain Dev; 2003 Oct; 25(7):522-4. PubMed ID: 13129598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypersensitivity syndrome due to 2 anticonvulsant drugs.
    Conilleau V; Dompmartin A; Verneuil L; Michel M; Leroy D
    Contact Dermatitis; 1999 Sep; 41(3):141-4. PubMed ID: 10475512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forced normalization induced by ethosuximide therapy in a patient with intractable myoclonic epilepsy.
    Yamamoto T; Pipo JR; Akaboshi S; Narai S
    Brain Dev; 2001 Mar; 23(1):62-4. PubMed ID: 11226734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possibility for provoking grand mal series in ethosuximide therapy--2 case reports].
    Findeis B
    Psychiatr Neurol Med Psychol (Leipz); 1990 Sep; 42(9):576-7. PubMed ID: 2126870
    [No Abstract]   [Full Text] [Related]  

  • 14. 50 Years Ago in TheJournal ofPediatrics: Occurrence of Systemic Lupus Erythematosus in Association with Ethosuccimide Therapy.
    Hashkes PJ
    J Pediatr; 2020 Apr; 219():53. PubMed ID: 32204806
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of ethosuximide on cortisol metabolism in the treatment of congenital adrenal hyperplasia.
    Yau M; Rao N; Nimkarn S; Vogiatzi M
    J Pediatr Endocrinol Metab; 2014 May; 27(5-6):549-54. PubMed ID: 24468605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethosuximide-induced Stevens-Johnson syndrome: Beneficial effect of early intervention with high-dose corticosteroid therapy.
    Tachibana K; Hamada T; Tsuchiya H; Shibata T; Fujii K; Kobayashi K; Iwatsuki K
    J Dermatol; 2018 May; 45(5):592-595. PubMed ID: 29430697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethosuximide treatment of petit mal seizures. A study of 87 pediatric patients.
    Weinstein AW; Allen RJ
    Am J Dis Child; 1966 Jan; 111(1):63-7. PubMed ID: 4954419
    [No Abstract]   [Full Text] [Related]  

  • 18. UV-photoconversion of ethosuximide from a longevity-promoting compound to a potent toxin.
    Choi H; Schneider H; Klum S; Chandler-Brown D; Kaeberlein M; Shamieh L
    PLoS One; 2013; 8(12):e82543. PubMed ID: 24340038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of forced normalisation psychosis with ethosuximide.
    Apap Mangion S; Rugg-Gunn F
    BMJ Case Rep; 2017 Dec; 2017():. PubMed ID: 29222216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Extrapyramidal symptoms during the use of anticonvulsants].
    Dreyer R
    Nervenarzt; 1969 Jan; 40(1):17-20. PubMed ID: 4982952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.